Treatment initiation or switch to BIC/FTC/TAF – real-world safety and efficacy data from two HIV centers in Romania
Author(s) -
Oana Săndulescu,
Mădălina Irimia,
Otilia Elisabeta Benea,
Mariana Märdärescu,
Liliana Preoțescu,
Carmen Dorobăţ,
Isabela Ioana Loghin,
I Nicolau,
Raluca Jipa,
R. Popescu,
Cristina Loredana Benea,
Alina Cozma,
Ioana Andreea Dărămuș,
Victor Daniel Miron,
Liviu Jany Prisăcariu,
Adriana Florina Bahnă,
Iriistor,
Oana Manuela Secrieru,
George Silvaș,
Andreea Bîrcă,
Loredana Dobrea,
Alexandra-Ștefana Șogorescu,
Ioana Viziteu,
Anca StreinuCercel
Publication year - 2021
Publication title -
germs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.652
H-Index - 12
ISSN - 2248-2997
DOI - 10.18683/germs.2021.1286
Subject(s) - medicine , tenofovir alafenamide , emtricitabine , tolerability , regimen , human immunodeficiency virus (hiv) , viral load , adverse effect , pediatrics , antiretroviral therapy , family medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom